Compare Ishares Msci Spain ETF (EWP) vs Moderna, Inc. (MRNA) Price & Performance

Ishares Msci Spain ETFTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Ishares Msci Spain ETF vs Moderna, Inc. — how do they compare? Ishares Msci Spain ETF trades at $59.09, while Moderna, Inc. trades at $65.33 (market cap $27.09B). The key difference: Ishares Msci Spain ETF is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	EWP	MRNA
Sector	Broad Market / Factor	Health
52-Week High	$60.28	$81.80
52-Week Low	$43.90	$22.36
Market Cap	—	$27.09B
Enterprise Value	—	$23.19B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ishares Msci Spain ETF

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $67.44, showing modest daily gains amid a bullish technical signal. The company continues to beat earnings expectations despite reporting significant net losses, with revenue declining from pandemic peaks to $1.92B in 2025. Recent positive developments include EU RSV vaccine contracts, Phase 1 cancer trial initiation, and FDA advisory panel support for its mRNA flu vaccine, driving recent stock momentum.

While Moderna's pipeline expansion beyond COVID-19 shows promise with oncology and rare disease applications, substantial financial risks persist with negative profit margins and cash burn. Analyst consensus remains cautious with a $49 price target below current levels, reflecting concerns about revenue sustainability versus pipeline execution risks and valuation metrics.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EWP

Spain's single-nation ETF leads World Cup finalists with 37.6% return, outperforming France, UK, and Argentina ETFs.ETF Trends · 2 days agoNeutral View details →

MRNA

Arbutus sues Pfizer/BioNTech over LNP patents, gets $178M from Moderna, plans $230M share buybackGlobeNewsWire · 7 hours agoNeutral Moderna's Q2 report expected uneventful; key focus on COVID vaccine demand and Phase III melanoma data.Proactive Investors · 2 days agoNeutral View details →

About Ishares Msci Spain ETF

EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.